The Effect of Adenotonsillectomy on Sleep Efficiency in Pediatric Patients

Basir S Mansoor1, Matthew Zhang1, Asim Mohamed1

  • 1Department of Otolaryngology UT Southwestern Medical Center Dallas Texas USA.

Insights

Adenotonsillectomy (T&A) improves sleep efficiency (SE) in children with obstructive sleep apnea (OSA). However, some patients, especially those with Down Syndrome (DS), experience worsening SE, indicating a need for personalized care.

Area of Science:

  • Pediatric Sleep Medicine
  • Otolaryngology
  • Respiratory Medicine

Background:

  • Obstructive sleep apnea (OSA) in children significantly impacts behavior and cognition.
  • Adenotonsillectomy (T&A) is a common treatment for pediatric OSA.
  • Sleep efficiency (SE) is a crucial marker of sleep quality and its impact on overall health.

Purpose of the Study:

  • To assess the effect of T&A on SE in children diagnosed with OSA.
  • To identify factors influencing SE changes after T&A.
  • To understand the implications of SE alterations for pediatric OSA management.

Main Methods:

  • Analysis of 139 children undergoing polysomnography (PSG) before and after T&A.
  • Stratification of patients into SE severity groups: normal (≥85%), mild-moderate (70%-84%), and severe (<70%).
  • Evaluation of changes in SE, apnea-hypopnea index (AHI), and sleep architecture post-T&A.

Main Results:

  • T&A led to significant improvements in SE for many children, with normal SE increasing and severe SE decreasing.
  • Median AHI decreased significantly post-T&A, confirming treatment efficacy for OSA.
  • While sleep architecture remained largely unchanged, respiratory parameters improved. Down Syndrome (DS) was linked to poorer outcomes, and the severe SE group experienced significant SE decline with high variability.

Conclusions:

  • T&A is effective in improving SE and resolving OSA in many pediatric cases.
  • A subset of patients, particularly those with comorbidities like DS, may experience worsening SE post-T&A.
  • Individualized postoperative care and further research into predictors of T&A outcomes are essential for pediatric OSA patients.
Abstract

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
3.5K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
15.7K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
626
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
5.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
939